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Thesis Abstract
Oxidative stress and excitotoxicity are considered to be two prominent mechanisms
underlying many CNS pathologies. Recent investigations have provided evidence that the
two events may be at least partially interconnected. Notably, Na^-dependent glutamate
transport was shown to be inhibited by oxidative stress. As glutamate transport is
responsible for regulating extracellular glutamate levels and preventing excitotoxic damage,
any loss in activity could potentiate excitotoxic injury. In the present study the
consequences of oxidative stress on both the Na"^ and Cl'-dependent high-affinity
glutamate transport systems was examined. Exposure of spinal cell cultures to either
xanthine + xanthine oxidase, a reactive oxygen species generating system, or hydrogen
perokide resulted in a significant decrease in both Na"^ and Cl'-dependent glutaihate
transport. Subsequent experiments demonstrated that the inhibition produced by the
oxidative insults was both time and concentration dependent. Though both transport
systems were susceptible to oxidative stress, Na"^-dependent transport demonstrated a
higher sensitivity to each insult. Further the two transport systems also displayed
differential sensitivity to the potential protective effects of various antioxidants.
Inhibition of Na^-dependent transport was significantly decreased in the presence of the
disulfide reducing agents glutathione and dithiothreitol, but not by lipophilic antioxidants
(a-tocopherol or methylprednisolone) or ascorbate. While the inhibition of Cl'-dependent
transport was attenuated only in the presence of a-tocopherol. These data suggest that
Na^ and Cl'-dependent transport are differentially sensitive to oxidative stress and that
this is probably due to seperate mechanisms of inhibition.
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INTRODUCTION
I. GLUTAMATE
Pioneering research by Hayashi (1952) and Curtis (1959) originally demonstrated
the ability of the a-amino acid L-glutamate to induce neuronal excitation. Following the
initial discovery of glutamate's neuro-excitant properties, work was undertaken to
characterize glutamate's excitatory actions. The finding however, that essentially all
neurons were stimulated by glutamate or structurally related analogues, termed excitatory
amino acids (EAA), led to the suggestion that the excitatory responses were the result of
a general property of neuronal membranes rather than specific transmitter receptors.
Furthermore, the ubiquitous distribution of glutamate, as well as its functions in
intermediary metabolism, distinguished it from the other known neurotransmitters (e.g., yaminobutyric acid (GABA), acetylcholine, and dopamine) and cast doubts on its
theorized role as a neurotransmitter. Appropriately, early investigations concentrated
upon demonstrating that glutamate meets the necessary criteria of a classic
neurotransmitter (for a review see Headley and Grillner, 1990).
In the past four decades scientific research has firmly established glutamate as a
neurotransmitter in the mammalian central nervous system (CNS). In addition, the
interest and knowledge in its excitatory role have grown tremendously. Consistent with
the classical mechanisms of neurotransmission, investigations have shown; (1) that
exogenously applied glutamate activates postsynaptic receptors in a manner similar to
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the endogenous transmitter (Cotman et. al., 1987); (2) that glutamate is sequestered in
synaptic vesicles and released from presynaptic terminals in a Ca^^-dependent manner
(Attwell and Nicholls, 1990); and (3) a high affinity glutamate transport system has been
identified and postulated to be involved in signal termination (Balcar and Johnston, 1972;
Rosenberg et. al., 1992). As a result of the above investigations, together with countless
others, glutamate is now recognized as the primary excitatory neurotransmitter of the
mammalian CNS (for review see Cotman et. al., 1995). Glutamatergic receptors have been
identified at a majority of synapses (see Multiple authors, 1987). Further, contemporary
findings have linked glutamate neurotransmission to the more complex neuronal processes
of learning and memory, development, and even neuropathology (for a review see
Monaghan et al., 1989).
The capacity of glutamate to mediate such a variety of roles in CNS signaling is
dependent upon a sophisticated multiple-class receptor system (Figure 1). This system is
a combination of at least five

receptor classes and includes both ionotropic and

metabotropic receptor families (Monaghan et al., 1989; Cotman et al., 1995). The
ionotropic receptor classes are distinguished and named by the selective agonists: Nmethyl-D-Aspartate (NMDA), kainic acid (KA), and a-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid (AMPA) (Monaghan et al., 1989). Molecular studies have
demonstrated that these receptors are heteroligomeric assemblies of subunits. These
receptors are coupled to both voltage-dependent and voltage- independent ion channels
that gate currents carried by Na"^, K"*", and in some cases, Ca^^.
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Figure 1. The Excitatory Amino Acid Synapse
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The metabotropic glutamate receptors activated by the agonists 2-amino-4phosphonobutyrate (AP4) and ^ra«5-l-amino-cyclopentyl-l,3-dicarboxylate (ACPD)
provide additional refinement to the system through G-protein coupled interactions with
the phosphoinositide (PI) and cyclic nucleotide (cAMP) second messenger systems
(Conn and Pin, 1997). Through its regulation of ionic influx and intracellular messenger
systems, presynaptically released glutamate can bring about both transient and stable
changes in the postsynaptic cell. Excitatory transmission appears to involve actions
mediated by one or more combinations of these receptors, even at single synapses.
Contradictory to its role in normal excitatory synaptic transmission, glutamate can
act as a potent neurotoxin when its extracellular concentrations become excessive (for a
review see Choi, 1992). This glutamate mediated neuronal injury, termed excitotoxicity by
Olney (1982), is thought to contribute to a number of neuropathologies. These include
acute injuries, such as in ischemia (Santos et al., 1996) and spinal cord trauma (Gardner et
al., 1990), as well as chronic neurodegenerative diseases including Huntington's disease
(Arzberger et al., 1997), amyotrophic lateral sclerosis (ALS) (Shaw and Ince, 1997), and
Alzheimer's disease (Olney et al., 1997). Significantly, in vivo studies with EAA receptor
antagonists have demonstrated attenuation of damage in animal models of excitotoxic
related neuropathologies (Schwarcz and Meldrum, 1985; Boeckman and Aizenman, 1996;
and Willis et al., 1993). This clearly suggests extracellular glutamate must be maintained at
a level sufficient to mediate excitatory transmission, but below the concentrations capable
of inducing excitotoxic injury.
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Since the initial description of excitotoxicity, a tremendous amount of research has
been initiated to better understand the mechanisms involved. The in vitro preparations of
cell culture and brain slice have principally been utilized in the investigations. An injury,
induced by brief, intense exposure to excitotoxic levels of glutamate in vitro can be
separated into two components, which are distinguished by differences in the time of
occurrence and ionic dependence. The first component, marked by neuronal swelling and
occurring within minutes of exposure, is dependent upon the presence of extracellular Na"^
and Cr (Choi, 1987; Rothman, 1985). This probably reflects the influx of Na"^, through
activated glutamate receptors and voltage-gated Na"^ channels accompanied by the passive
influx of cr and water, inducing neuronal swelling. The significance of this in vivo may be
less, if one considers that the environment of in vitro preparations may allow exaggeration
of cell volume expansion.
The second component of in vitro excitotoxicity is marked by
neurodegeneration occurring over a period of hours after exposure. This component is
dependent upon the presence of extracellular Ca^^ and is most likely due to the excessive
influx of Ca^"^ (Choi, 1985). Activated NMDA receptors, voltage-gated Ca^"*" channels, and
the reversal of the Na+/Ca^"^ exchanger have all been postulated to function to increase
intracellular Ca^^ during excitotoxic injury. Intracellular Ca^^ acts as a second messenger in
the normal cell, activating proteases, lipases, and cyclooxygenases. A sustained rise in
intracellular Ca^^ levels and continual activation of these intracellular enzymes can set in
motion several destructive cascades. Acute excitotoxicity and excitotoxicity associated
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with long term neurodegenerative pathologies have been hypothesized to be linked by
these cytotoxic

activated cascades. Although either component of excitotoxicity in

many in vitro preparations can induce neuronal death, with lower glutamate
concentrations most neurons die from the delayed Ca^^ component.

n. REGULATION OF EXTRACELLULAR GLUTAMATE
Maintenance of extracellular glutamate below excitotoxic levels is dependent upon
rapid clearance from the synaptic cleft and surrounding extracellular spaces. This is
achieved by diffusion of glutamate away from the synaptic junction as well as by high
affinity transporters, with little or no extracellular metabolism (for a review see Kanai et
al., 1993). These transporters are integral membrane proteins, which mediate the
translocation of glutamate across the plasma membrane of the presynaptic terminals and
surrounding astrocytes. Transporters on presynaptic termini sequester glutamate directly
from the synaptic cleft. At the same time, transporters located on astrocytes maintain
low extracellular glutamate concentrations, thereby establishing a diffusion gradient
favoring the movement of glutamate out of the synaptic cleft and into the extracellular
space (for a review see Schousboe et al., 1997). The cell's ability to remove glutamate
from the extracellular environment is considered to be essential in terminating the
excitatory signal, recycling the transmitter, and maintaining extracellular glutamate below
that which is capable of inducing excitotoxic injury (Attwell and Nicholls, 1990;
Schousboe, 1988; Shank and Aprison, 1981).
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Similar to the diversity of the EAA receptor system, evidence has established that
high-affinity EAA transport is not mediated by a single system. Pharmacological and
kinetic studies have shown variations in this system as a function of both location and
ionic-dependence (Anderson et. al., 1990; Rothstein et. al., 1994). Classically the EAA
transporters have been placed into one of two distinct systems, Na^-dependent or Cl"dependent. Of the two systems, the high-affinity sodium-dependent glutamate
transporter system has been the most extensively studied in terms of its pharmacology,
mechanisms, distribution, and molecular biology (for a review see Kanai et. al., 1994). The
Na^-dependent system is a Na"*"/L-Glu co-transporter that is driven by an electrochemical
Na"^ gradient across the plasma membrane in neurons and glial cells (Kanner, 1983). At
least five Na^-dependent transporters have been cloned from the human CNS and termed
EAATl, EAAT2, EAAT3, EAAT4, and EAAT5 (for excitatory amino acid transporter)
(Arriza et. al., 1994; Fairman et. al., 1995; Arriza et. al., 1997). The three human
transporters EAATl, EAAT2, and EAAT3 were cloned from the motor cortex, EAAT3
is expressed in neurons, whereas EAATl and EAAT2 are expressed in glia. Three
homologs have been cloned from the rat GLAST (EAATl), GLT-1 (EAAT2), and
EAACl (EAAT3) (Storck et. al., 1992; Pines et. al., 1992; Kanai and Hediger, 1992). The
fourth transporter, EAAT4 (Fairman et al., 1995) is expressed in purkinje fiber neurons
of the cerebellum and the fifth, EAAT5 (Arriza et al,1997), is expressed in retinal
neurons.
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Pharmacological characterization of the Na^-dependent transport system was
initially based upon the ability of a wide variety of EAA analogues to inhibit the uptake
of radiolabeled substrates (e.g., ^H-L-glutamate and ^H-D-aspartate) into synaptosomes,
cultured astrocytes, and tissue slices. Interestingly the sodium-dependent transporters
demonstrate some stereoselectivity with a preference for L-glutamate over the enantiomer
D-glutamate, yet both L- and D-aspartate are excellent substrates. The investigations
demonstrated that generally inhibitors were a-amino acids with a second acidic group
separated from the a-COOH by 2-4 methylene groups (Roberts and Watkins, 1975).
Since the early studies the design and use of conformationally constrained analogs of
glutamate, such as L-?ra«.y-2,4-pyrrolidine dicarboxylate and L-fl«?/-e«Jo-methanopyrrolidine dicarboxylate, has allowed the development of much more detailed models of
the transporter pharmacophore (Bridges et. al., 1991; Bridges et. al., 1994).
A second transport system was identified based upon its dependence on the
presence of CI'. This transporter was originally thought to be an AP4-like EAA receptor
and thus its pharmacology was initially defined through binding studies rather uptake
assays (Fagg and Lanthom, 1985; Bridges et al., 1986). Later investigations confirmed its
identity as a transporter and established its presence in a spinal glial cell line and in nerve
terminals (Waniewski and Martin, 1984; Zaczek et. al, 1987). A more thorough
investigation of Cl'-dependent transport pharmacology has been slowed by the extremely
low activity of this system present in classical physiological preparations. In cortical
synaptosomes Cl'-dependent uptake accounts for less than 10% of total uptake
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(unpublished data). Significantly, there is evidence that there may be a greater proportion
of Cl'-dependent transport in the spinal cord as compared to the brain (Mena et al.,
1986). The identification of an astrocytoma cell line (LRM-55) that expresses a high level
of Cl'-dependent uptake activity has recently accelerated the pharmacological
characterization of this system (Waniewski and Martin, 1984). While still not thoroughly
defined, the pharmacology of the system exhibits considerable homology to the
cystine/glutamate antiporter, designated as system X'^ (Murphy et al., 1989; Patel et al.,
1998). The X"c system transports cystine intracellularly and glutamate extracellularly
vyith the glutamate gradient providing the driving force (Bannai, 1986). The cystine taken
up is intracellularly reduced to cysteine and then utilized to synthesize glutathione. The
significance of distinguishing and characterizing the glutamate transport systems goes well
beyond basic biochemical research, it is central to; (/) evaluating their respective roles in
excitatory physiology and pathology, (ii) accurately identifying changes that accompany
age or diseases, and (///) assessing the consequences of reduced function.
The crucial role of the glutamate transport systems becomes even more apparent
when investigating potential pathological consequences of reduced function. For example,
in vivo pathology produced by L-glutamate is exacerbated when co-administered with (3threo-hydroxy aspartate, an inhibitor of Na^-dependent uptake (Mcbean and Roberts,
1985). In addition, the inverse relationship between excitotoxic damage and transport
capacity is supported by the finding that much larger amounts of L-glutamate are required
to produce lesions in vivo than compared to EAA agonists that are not easily transported
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(Mangano and Schwarcz, 1983). Further, in vitro studies with a glioma cell line have
demonstrated a mechanism of glutamate toxicity that involves inhibition of the X'c
transporter and depletion of glutathione (Kato et al., 1992). Abnormalities in glutamate
transport have now been linked with specific neuropathologies. Palmer et al., (1986)
reported a reduction in the number of glutamate transport sites in Alzheimers disease. In
addition, a significant decrease in glutamate uptake velocity has been demonstrated in
synaptosomes prepared from the spinal cords of patients with ALS (Rothstein et. al.,
1992).

III. OXIDATIVE STRESS
Oxygen free radicals including the hydroxyl radical (HO*), superoxide anion (OV),
and hydrogen peroxide (H2O2), are continuously produced during normal cellular
respiration. The initial reduction of molecular oxygen leads to the formation of the
superoxide anion radical. The superoxide anion then dismutates with its conjugate acid,
the perhydroxyl radical, to form hydrogen peroxide. By definition hydrogen peroxide is
not a free radical, but it readily participates in reactions that generate fi-ee radicals, an
important example of which, is the reaction between hydrogen peroxide and iron to form
the hydroxyl radical (reviewed by Halliwell and Gutteridge, 1990). These reduced forms
of oxygen are generally very reactive chemical species and are collectively called reactive
oxygen species (ROS). They can easily abstract hydrogen atoms or add to double bonds
present in a variety of important macromolecules (e.g., lipids, proteins,

and

11

carbohydrates). Not only does this lead to significant damage to the macromolecule itself,
but also to the generation of other radicals contributing to the development of chain
reactions. The unsaturated bonds of membrane cholesterol and fatty acids are particularly
susceptible to this process, since each lipid peroxide generated is also a free radical that
can attack a neighboring fatty acid to yield additional lipid peroxide products (Bast and
Goris, 1989). The peroxidation of these unsaturated fatty acids can produce changes in
membrane fluidity, alter the function of integral proteins (e.g., transporters) and promote
cellular lysis (Dirks et al., 1982; Hill, 1985, Jesberger, 1991; Leam et al., 1988).
Inactivation of enzymes and receptors can result from free radical-mediated crosslinking,
side chain modifications, fragmentation, and denaturation (Jesberger, 1991).
Protein function, particularly receptors and transporters, may also be affected by
oxidative damage to their primary structure. The aromatic amino acids trytophan,
tyrosine, and phenylalanine are the sensitive because they contain unsaturated bonds
(Kleinveld et al., 1989). The sulfur-containing amino acids cysteine and cystine are
particularly susceptible to the actions of free radicals owing to sulfhydryl-disulfide
interconversion. Although less vulnerable than lipids and proteins, ROS, especially the
superoxide anion, can induce base modifications and backbone nicking in DNA (Floyd,
1991; Jesberger, 1991; Bimboim, 1988).
Under normal circumstances, endogenous antioxidants detoxify the oxygen free
radicals that are generated with sufficient efficiency that their presence in cells is
insignificant. Physiologically important antioxidants include both enzymatic and non-
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enzymatic protective systems, which are generally distributed in such a manner that cells
possess a compliment of overlapping systems (Halliwell and Gutteridge, 1992).
Antioxidant enzymes include superoxide dismutase (SOD), catalase (Cat), and glutathione
peroxidase (GPX) (for review see Wilson, 1997). The SODs are a group of
metalloenzymes that catalyze the transformation of the superoxide radical into hydrogen
peroxide and water. The group includes the CuZn-SOD present in the cytosol and the
Mn-SOD found within mitochondria. The catalysis of hydrogen peroxide to water and
molecular oxygen is carried out by either GPX or Cat. Cat is a heme-containing enzyme
present in peroxisomes, while GPX is a selenium-containing enzyme localized in both the
cytosol and mitochondria.
The non-enzymatic protective mechanisms rely on the presence of molecules (e.g.,
reduced glutathione (GSH), a-tocopherol (Vitamin E), and ascorbate) that can react with
free radicals and form non-toxic stable intermediates. GSH, which is the major non
protein thiol in cells, directly participates in the detoxification of radicals and peroxides,
assists in the recycling of other antioxidant systems, and protects against radical induced
injury by repairing oxidative damage to protein and nucleic acids (Shan et al., 1990). aTocopherol is a lipid soluble free radical scavenger found within cellular membranes. As a
result of its ability to form stable non-deleterious radicals, a-tocopherol can effectively
detoxify the hydroxyl radical. Its most important role, however, appears to be in
quenching the chain reactions that promote the peroxidation of lipids within membranes
(Burton et al., 1985). a-Tocopherol can be regenerated from its radical form by a GSH-
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dependent reductase and by the water-soluble antioxidant ascorbate (Burton et al., 1985).
In addition to its role in recycling a-tocopherol, ascorbate can also react with superoxide,
the hydroxyl radical, and singlet oxygen. It has been suggested that the production of
these ROS during normal cellular functioning are just balanced by the capacity of the
endogenous protective systems to detoxify them. Under pathological conditions however,
ROS can overburden these antioxidant systems and begin to accumulate. This disparity
between the rates of free radical production and elimination is referred to as oxidative
stress.
The central nervous system (CNS) is extremely susceptible to ROS-mediated
damage due to a large lipid content, high rate of oxidative metabolism, and relatively low
levels of antioxidants. Accordingly, oxidative stress has been associated with both acute
(e.g., stroke, epilepsy and spinal cord trauma) and long-term (e.g., Alzheimer's, and ALS)
neuropathologies (for review see Gotz et al., 1994; Choi, 1993; Halliwell, 1992).
This association was originally suggested because of a shared connection to the
pathogenesis of several CNS disorders. The potential ties between excitotoxicity and
oxidative stress are particularly evident in the pathology of ischemic brain injury and
spinal cord injury. Abnormal elevations of extracellular glutamate are reported to occur
during both ischemic insults (Santos et al., 1996) and spinal cord injury (Lui et al., 1991).
Significantly, an increased production of ROS has also long been connected to the
pathologies of ischemia/reperfusion injury (Cao et al., 1988; Bromont et al., 1989) and
spinal cord trauma (Iwasa et al., 1989; Lemke et al., 1990).
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Several subsequent investigations have developed the underlying connection
between excitotoxicity and oxidative stress. Additionally, the findings established the
possibility that these two pathological mechanisms may be at least partially
interconnected. In summary, (1) excessive levels of glutamate will decrease the levels of
the free

radical scavenger glutathione, resulting in enhanced peroxide accumulation

(Murphy et al., 1989); (2) inhibitors of lipid peroxidation and antioxidants can eliminate
neuronal death in culture following exposure to glutamate receptor agonists (Miyamoto et
al., 1989; Monyer et al., 1990); and (3) release of EAA in hippocampal slices exposed to
an in vitro model of ischemia was blocked by the addition of free radical scavengers and
reproduced by free-radical generating systems (Pellegrini-Giampietro et al., 1990).
More recent studies have demonstrated that once established, oxidative stress may
in fact potentiate excitotoxic injury through the inhibition of glutamate uptake.
Investigations have demonstrated that the Na^-dependent transport system is vulnerable
to the deleterious actions of ROS. Studies show that the exposure of cortical astrocyte
cultures to the free-radical

generating system xanthine/xanthine oxidase, the ROS

hydrogen peroxide or the free

radical peroxynitrite can significantly decrease Na"^-

dependent glutamate transport (Volterra et al., 1994; Trotti et al., 1996). In addition,
Agostinho et al., (1997) demonstrated that Na^-dependent glutamate transport in retinal
cultures is inhibited by ascorbate/Fe^^ induced oxidative stress. The decreases in uptake
function were reported to be a result of oxidatively sensitive sulfhydryl group(s) located
near or on the transport protein itself. Given the importance of the transporters in
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maintaining low extracellular levels of glutamate, these findings indicate a connection
between oxidative stress and the process of excitotoxic injury. Significantly, there has
been no report of how oxidative stress may acutely effect Cl'-dependent transport
function.

IV. SPECIFIC AIMS
The present study was undertaken to examine the consequences of oxidative
stress on both the Na"^ and CI" -dependent glutamate transport systems. This
investigation utilized the rat glioma cell line LRM55. The LRM55 cell line, originally
isolated from a spinal cord astrocytoma proved to be an excellent system for this study
for the following reasons: 1) the simplicity of an in vitro preparation; 2) it is an
established cell line; 3) it expresses significant levels of both Na"^ and CI" -dependent
glutamate uptake; and 4) ionic substitutions allow the transport systems to be studied
independently. In addition, utilization of the LRM55 cultures allowed the examination of
the consequences of oxidative stress on glutamate transport in a cell line that may reflect
spinal systems. This is of importance because excitotoxic injury has been implicated in
the pathologies of ALS and spinal cord trauma (Rothstein et al., 1992; McAdoo et al.,
1997). Specifically the aims of this study can be listed as follows:

1) To determine if oxidative stress attenuates Na"^ and CI' -dependent glutamate transport.
Two inducers of oxidative stress were utilized: xanthine/xanthine oxidase and hydrogen

16

peroxide. The two transport systems were selectively studied by ionic substitution
(choline for Na"^ and gluconate for CI').

A) To characterize the concentration and time-dependent decrease of glutamate
uptake activity by hydrogen peroxide. The dose-dependency was examined with
four concentrations of hydrogen peroxide. The exposure period of the cells to
hydrogen peroxide was also varied. Parallel studies were conducted to further
characterize the effects of hydrogen peroxide. These included:
i) Superoxide dismutase and catalase (alone and in combination) to prevent
oxidative stress
ii) Quantification of LDH activity as a indicator of cell viability

B) To characterize the concentration and time-dependent decrease of glutamate
uptake activity by xanthine/xanthine oxidase. The concentration of xanthine was
kept constant, while the xanthine oxidase concentrations were varied. Additionally
the exposure period of the cells to xanthine/xanthine oxidase was varied. Parallel
studies were conducted to further characterize the effects of xanthine/xanthine
oxidase. These included;
i) Xanthine alone
ii) Xanthine oxidase alone
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iii) Superoxide dismutase and catalase (alone and in combination) to prevent
oxidative stress
iv) Quantification of LDH activity as a indicator of cell viability

2) To determine the ability of antioxidants to attenuate inhibition of glutamate transport
induced by oxidative stress. Both lipophilic (vitamin E and MP) and hydrophilic (vitamin
C and GSH) antioxidants, as well as the reducing agent DTT, were tested as potential
protectants.

These studies should improve the current understanding of the effects of oxidative stress
on glutamate transport. The investigation supplements and reinforces the present body of
information examining the consequences of oxidative stress on Na^-dependent transport.
Furthermore, this investigation presents the first analysis of the Cl'-dependent transport
system following exposure to oxidative stress. The results of this study provide insight
into how oxidative stress and excitotoxicity may function in concert to induce pathology.
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MATERIALS AND METHODS

Cell Culture LRM55 glioma cells were obtained from the laboratory of David Martin
(Wadsworth Center, Albany, NY), where the line was developed. LRM55 astrocytoma
cells were grown in modified Ham's F-12 (GibcoBRL 21700-075) medium (pH 7.4). The
following changes were made with respect to F-12: concentrations of each amino acid
were supplemented to obtain a final concentration (mM), L-alanine (0.2), L-arginine (2.0),
L-asparagine (0.17), L-aspartic acid (0.2), L-cysteine (0.4), L-glutamic acid (0.2), Lglutamine (2.0), L-glycine (0.2), L-histidine (0.2), L-isoleucine (0.06), L-leucine (0.2), Llysine (0.4), L-methionine (0.06), L-phenylalanine (0.06), L-proline (0.6), L-serine (0.2),
L-threonine (0.2), L-trytophan (0.2), L-tyrosine (0.06), L-valine (0.2); ascorbic acid was
added to 75 wM; and the concentrations of the following compunds were: 2.0 pyruvate,
11 mM glucose, 5 mM KCL, 0.85 mM MgCl2, 0.15 MgSO^, 2 mM CaCl2, 0.5 wM
ZnS04, and 23.5 mM NaHCO). The culture media was supplemented with 5% fetal calf
serum and a mixture of penicilin (100 U/mL), streptomycin (100 wg/mL), and fungizone
(0.1 wg/mL). Cells were cultured in 150 cm^ flasks (Coming 430824) and maintained at 37
°C

in a humidified atmosphere of 5% CO2. Cells were lifted from the flasks by the

addition of ImL 1.25% trypsin for 3-5 minutes at 37 "C for passage every seven days. At
the time of passage, cells were seeded in 12 well plates (Coming 62408-597) at a density
of 5x10^ cells/well for use in the experiments. Only passages between # 7 and #17 were
utilized in the present work. Cells formed a confluent monolayer in 5 to 7 days with an
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estimated density of 2 5 10^ cells/well and a protein concentration of 100-300ug/well. The
medium was changed on the day of the experiment at least two hours prior to assays.

LRM55 transport assay

LRM55 astrocytes, after removal of culture media, were

preincubated in the presence of indicated agents at 37 °C in a humidified atmosphere of
5% for 15 min (unless otherwise stated) with HEPES buffered (pH 7.4) transport
solutions. Where indicated the transport buffers were altered by ionic substitution to
isolate the Na"^ and Cl'-dependent transport systems. The buffers contained (mM), (1)
Control (Na"^ and Cl'-dependent): 137 NaCl, 5.1 KCl, 0.77 KH2PO4, 0.71 MgS04»H20,
1.1 CaCl2, 10 glucose; (2) Na"^-dependent: ISONaCgHnO?, 5 KCgHnO?, 1.1 CaCgHnO?,
0.77 KH2PO4, 0.71 MgS04»7H20, 10 glucose; and (3) Cl'-dependent; 137.5 C5H14NOCI,
5.36 KCl, , 0.77 KH2PO4, 0.71 MgS04»7H20, , 1.1 CaCl2, 10 glucose. Following the
preincubation period, the plates were transfered to a 30 °C waterbath and each well
sequentially washed three times with 1 mL of the indicated transport buffer. The uptake
assays were initiated by aspiration of buffer and the addition of 1 mL of 100 fxM ^H-Lglutamate (44.0 Ci/mmol; NEN: isotopic dilution 1:125) prepared in the indicated
transport buffer. The assay was allowed to incubate for 5 or 10 minutes (Na^-dependent
uptake was only measured at 5 min). The assays were terminated by three sequential 1
mL washes with ice-cold buffer, and then cells were dissolved in 1 mL of 0.4 M NaOH
for 24 h. An aliquot (200 |iL) was then transferred into a 5.0 mL glass scintillation vial
and neutralized with the addition of 5 |iL glacial acetic acid, 3.5 mL Liquiscint@
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scintillation fluid (National Diagnostics) was then added to each sample. Incorporation of
radioactivity was then quantified by liquid scintillation counting (LSC, Beckman LS
6500). Values reported are corrected for non-specific radioactive incorporation i.e., uptake
at 4 °C. Protein content for each plate was determined by the bicinchoninic acid (BCA)
method (Smith, et al., 1985), with BSA utilized to construct the standard curves.
In the experiments where uptake was measured after exposure to either xanthine +
xanthine oxidase (X/XO) or H2O2 for 15 minutes (unless otherwise specified), the
reaction generating the radicals was terminated by aspiration of the supernatant and the
addition of a mixture of superoxide dismutase (SOD) (90 U/mL) and catalase (Cat) (3000
U/mL). The wells were then sequentially washed twice more with 1 mL of indicated
transport buffer, equilibrated to 30 °C, before beginning the uptake assays. When the
antioxidants or SH reagents were examined, they were added simultaneously with the
free-radical generating systems during the preincubation.

Lactate dehydrogenase activity assay

Lactate dehydrogenase (LDH), was used as a

marker of cell viability (Koh and Choi, 1987). Enzyme activity was quantified in
intracellular and extracellular samples taken from

cells incubated under control and

experimental conditions. Following the incubation period, extracellular samples were
collected by removal of the supernatant. Intracellular samples were collected by lysing the
cells with the detergent Triton X-100 (0.1%) for one hour on a rotating shaker at room
temperature. The samples were stored in the refrigerator overnight, after which LDH
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activity was quantified. LDH activity was determined by quantifying the rate of
disappereance of NADH from the reaction mixture (AOD340) using a Molecular Devices
96 well plate reader and SOFTmax PRO software. Values were presented as percent of
control LDH activity ± SEM.

Statistical Analysis Statistical analysis was determined with the InStat 2.01 software
program. Results were compared and p values (two-tailed) calculated using the Alternate
Welch t-test with unpaired values. The Alternate Welch t-test is comparable to a student
t-test in which the Gaussian population of the two groups have unequal standard
deviations (InStat).

Materials

Xanthine oxidase (0.4-1.0 U/mg protein)) was obtained from Sigma. The

activity of the enzyme was confirmed spectrophotometrically using the extinction
coefficient of uric acid at 290 nm (£240 = 12.2 M"' cm"') (Bergmeyer et al., 1974). H2O2
was purchased from VWR. H2O2 assay solutions were prepared fresh, from the 30 %
stock solution. The other enzymes, superoxide dismutase (2,000-6,000 U/mg protein) and
catalase (40,000-60,000 U/mg protein), and reagents: xanthine, reduced glutatione, DLdithiothreitol (DTT), 6a-methylprednisolone (MP), allopurinol, «-tocopherol (Vitamin
E), and ascorbate were purchased from Sigma (St. Louis, MO). In addition, all agents used
to prepare the indicated transport buffers were obtained from Sigma.
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RESULTS

High-affinity glutamate uptake in the LRM55 cell line
The activity of the high-affinity L-glutamate transport systems in LRM55 cells was
determined by quantifying the intracellular accumulation of ^H-L-glutamate as described
in Methods. The uptake of ^H-glutamate (100 uM) was measured in both Na'^-fi'ee
(choline-substituted) and Cl'-free (gluconate-substituted) buffers to quantify the
individual contributions of Na"^ and Cl'-dependent systems to total uptake. A substrate
concentration of 100 wM was utilized in all experiments, as it is comparable to the
value of both the Na"^ and Cl'-dependent transporters present in the LRM55 cell line (i.e.
134 ± 4 wM and 56 ± 4 mM, respectively) (Patel, et al., 1997). Previous work has shown
that under the described assay conditions uptake is linear for at least ten minutes
(Wanieski and Martin, 1984). The transport rates are reported as pmol/min/mg of protein
and have been corrected for backround binding and non-specific uptake by subtracting the
accumulation of ^H-L-glutamate occurring at 4°C. This non-specific uptake typically
represented 5% of total uptake. As reported in Table 1, the Na^-dependent and Cl'dependent systems contribute approximately 65% and 35% respectively to the total
uptake of ^H-L-glutamate. The values were similar to those previously reported by
Wanieski and Martin (1984).
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Effects of H2O2 on high-affinity glutamate transport
The consequences of oxidative stress on the Na"^ and Cl'-dependent high-affinity
glutamate transporters was first investigated by exposing LRM55 cell cultures to a range
of concentrations of H2O2 (0.1 - 10 mM). Cells were exposed to the oxidative insult for
15 minutes, after which the H202-contaimng buffer was removed. Each well was then
washed three times sequentially; first with 1 mL of the mixture of free radical scavengers
(Cat (3000 U/mL and SOD 90 U/mL) and twice more with one mL of the indicated buffer.
Uptake assays were then performed as described in Methods. In response to H2O2 the
Na^-dependent transport system exhibited a dose-dependent decrease in glutamate uptake
(Figure 2). The rate of glutamate transport as compared to control values (215.2 ± 1.8
pmol/min/mg) was significantly attenuated, even at the lowest concentration of H2O2 (0.1
mM) (171.4 ±3.1 pmol/min/mg). Transport activity continued to decrease, diminishing to
30.1 ± 1.5% of control at 10 mM H2O2. The inhibition of uptake produced by the
addition of H2O2 appeared to plateau at 5 mM, as a significant decrease was not observed
when the H2O2 level was increased to 10 mM H2O2. Importantly, the addition of a
mixture of the free-radical scavenger enzymes Cat (3000 U/mL) and SOD (90 U/mL) to
the preincubation with 5 mM H2O2 almost completely abolished the observed inhibition
(204.8 + 2.3 pmol/min/mg). Neither SOD (90 U/mL) nor Cat (3000 U/mL) alone or in
combination modified Na^-dependent glutamate uptake in the absence of H2O2 (data not
shown). Additional studies revealed that while Cat (3000 U/mL) alone was able prevent
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H202-induced (1 mM) inhibition (98.9 ± 0.6%), SOD (90 U/mL) was only slightly
effective (57.3 ± 3.3%) (Figure 3).
Analogously, the transport of glutamate by the Cl'-dependent system displayed a
concentration-dependent decrease in uptake following exposure to H2O2 (Figure 4). Once
again, there was a significant decrease in the rate of uptake at the lowest concentration of
H2O2 ( (106.9 ± 2.2 pmol/min/mg at O.lmM H2O2) as compared to control (121.9 ±1.7
pmol/min/mg). At the highest concentration of H2O2 examined (10 mM), the activity of
the transporter was inhibited 50.8 ± 2.4%. Unlike the Na^-dependent system, the
inhibition of Cl'-dependent transport did appear to plateau, as a significant decrease in
activity between 5 and 10 mM H2O2 was observed (P<0.001). The addition of the Cat
(3000 U/mL) and SOD (90 U/mL) fi-ee-radical scavenger mixture was able to completely
eliminate the inhibition produced by 5 mM H2O2. Neither SOD (90 U/mL) nor Cat (3000
U/mL) alone or in combination modified Cl'-dependent glutamate uptake in the absence of
H2O2 (data not shown). As was observed with the Na^-dependent system, Cat (3000
U/mL) alone prevented the inhibition of Cl'-dependent transport due to 1 mM H2O2
(99.1 ± 1.5%) exposure while SOD (90 U/mL) alone did not (69.8 ± 2.5%) (Figure 5).
To address the time-dependency of H202-induced inhibition of Na"^ and Cl'dependent transport, a time course of varying preincubation periods was performed. Cells
were exposed to 1 mM H2O2 for 5, 10, 15, or 30 minutes, followed by removal of the
reactive oxygen species-containing buffers. Individual wells were then washed in the same
manner as described after the 15 minutes exposure to H2O2. Uptake assays were then
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performed to determine the degree of inhibition as compared to controls at each exposure
time. In the presence of 1 mM H2O2, both Na"^ and Cl'-dependent transport displayed a
temporal pattern of inhibition, increasing with longer exposure times (Figure 6). After
incubation with H2O2 for 30 minutes, both Na"^ and CI' -dependent transport systems
displayed significant levels of inhibition, 82.6 ± 0.7% and 57.6 ± 2.5%, respectively
(Figure 6). Importantly, the free radical scavengers were able to attenuate inhibition of
Na"^-dependent (100.0 ± 1.5%) and Cl'-dependent (96.1 ± 3.5%) transport at this longer
incubation time (Figures 3 and 5).
As shown in Figure 6, there was a significant difference in the extent to which the
Na"^ and Cl'-dependent transport systems were inhibited when exposed to the same insult
(1 mM H2O2). This difference was observed at each time point examined. Additionally,
comparison of the dose-dependent changes in the percent of inhibition of the two
transport systems was found to be significantly different at each concentration (Table 2).
For example, while a 15 minute exposure to 5 mM H2O2 produced a 62.3 ± 1.2% decrease
in Na^-dependent transport, Cl'-dependent uptake was only reduced 44.7 ± 0.9%. As the
cells were treated under the same assay conditions, it is likely that these differences are
attributable to the individual vulnerability of the two transporters.
To exclude the possibility that the observed inhibition by H2O2 was due to a
general cytotoxic effect, intracellular and extracellular LDH activity was quantified as an
indicator of cell viability. As reported in Figure 7, a 15 minutes incubation with H2O2
(0.1-10 mM) did not significantly decrease the intracellular LDH content as compared
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to control values. Further, a 30 minutes exposure to 1 mM H2O2, which induced the
highest degree of inhibition, produced little or no change in LDH content compared to
control cells (Figure 7). In each instance, the amount of extracellular LDH activity was
below the level of detectibility.

Effects of X/XO on high-affinity glutamate transport
In a second set of experiments, cell cultures were exposed to a free-radical
generating system of xanthine/xanthine oxidase (X/XO). Once again the two transport
systems were selectively studied by ionic substitution. In these experiments the xanthine
concentration was maintained at 500 |iM, while the concentration of the enzyme,
xanthine oxidase was varied (5, 50, 200, or 500 mU/mL). Spectrophotometric analysis
confirmed the activity of XO was correct in terms of the units of activity reported by
Sigma at 25 "C. Further analysis demonstrated no variance of activity within each of the
transport buffers used. A 43% increase in rates was, however, observed when the assay
temperature was raised to 37 "C. For clarity, all reported activity units of XO were based
upon the value reported by Sigma at 25 °C. The concentration of xanthine utilized (500
wM) assured that substrate availability did not become a complicating factor, even at high
enzyme levels. The cells were exposed to the free-radical generating system for 15
minutes, after which the reactive oxygen species-containing supernatant was removed.
The individual wells were then washed three times sequentially; first with one mL of the
mixture of free radical scavengers (Cat 3000 U/mL and SOD 90 U/mL) followed by 2 X 1
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mL rinses with the indicated buffer. Uptake assays were performed as described in
Methods.
Cell cultures exposed to varying concentrations of XO displayed a concentrationdependent decrease in Na"^-dependent glutamate uptake as compared to control values
(Figure 8). Even at the lowest concentration of XO examined (5 mU), uptake was
significantly lower (173.4 ± 3.8 pmol/min/mg) than that observed in untreated controls
(204.3 ± 2.0 pmol/min/mg). Transport activity was almost completely absent when the
cells were exposed to (500 |iM) X/(500 mU/mL) XO (15.5 ± 3.9%). Control studies
demonstrated that 500 |_iM xanthine alone had no effect on glutamate uptake (Figure 8).
Interestingly XO, in the absence of xanthine, induced a slight inhibition (9.8%) of
glutamate uptake when included at a level of 50 mU/mL. Previous work by Volterra et al.
(1994), reported that this was due to proteolytic enzyme contamination of the xanthine
oxidase. Attempts to clarify this issue by including 1 mM allopurinol, a specific inhibitor
of XO (Kelley and Beardmore, 1970), confirmed that inhibition of uptake could not be
attributed solely to XO activity. A mixture of protease inhibitors (leupoprotein 1 |ig/mL
and aprotinin 2 |ig/mL) was then co-added to the solutions of 200 and 500 mU XO in an
effort to block the proteolytic-associated inhibition. This mixture however, was unable to
markedly reduce inhibition, presumably due to insufficient concentrations or specificity
of the protease inhibitors. The inability to resolve the issue leaves in question the exact
contribution of the proteolytic enzyme contamination to the total inhibition observed at
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high levels of XO (200 and 500 mU X/XO). Importantly, all further Na^-dependent
uptake experiments utilizing the X/XO system were conducted with 50 mU of XO, at
which the inhibition due to contamination was established at less than 10%. When the
mixture of free-radical scavenger enzymes Cat (3000 U/mL) and SOD (90 U/mL) was
added to the preincubation with 50 mU X/XO, inhibition of uptake was reduced to a level
comparable to that observed with 50 mU XO alone (Figure 8). Supplementary studies
revealed that both Cat (3000 U/mL) and SOD (90 U/mL) alone (67.6 ± 8.0%, 73.7 ±
4.0%, respectively) were able to attenuate the inhibition due to X/XO preincubation, but
to a level that was significantly lower than when both were added in combination (91.7 ±
0.0%) (Figure 9).
The Cl'-dependent uptake of glutamate in cultures exposed

to

varied

concentrations of XO was also inhibited in a dose-dependent manner (Figure 10). Though
the lowest concentration of X (500 |iM)/XO (5 mU/mL) was unable to significantly
inhibit transport, a significant decrease in uptake rate was observed at the 50 mU level
(72.9 ± 4.2 pmol/min/mg) when compared to control (111.3 ± 3.0 pmoL/min/mg). At 500
mU of X/XO, the Cl'-dependent uptake of glutamate was inhibited to 42.2 + 2.5% of
control. Additional experiments demonstrated that 500 |iM X alone had no effect on Cl'dependent uptake. As was the case with the Na^-dependent system, XO alone produced
some inhibition, most likely due to proteolytic contamination. Subsequent experiments
were conducted with 50 mU/mL of X/XO at which inhibition due to contamination was
previously established (Figure 10). The addition of the Cat (3000 U/mL) and SOD (90

29

U/mL) mixture to the preincubation with 50 mU/mL of X/XO was able to attenuate
inhibition to 90.1 ± 2.1% of control, a level comparable to that produced by XO in the
absence of xanthine. Further experiments demonstrated Cat (3000 U/mL) and SOD (90
U/mL) alone (83.2 ± 1.1%, 82.6 ± 3-7%; respectively) were able to decrease inhibition
due to 50 mU X/XO preincubation, but to a level that was considerably lower than the
two in combination (95.6 ± 4.0%) (Figure 11).
To further examine the consequences of oxidative stress induced by the X/XO
free-radical generating system, a time course of the inhibitory action on Na"^ and Cl dependent transport was investigated. Cells were exposed to X (500 wM)/XO (50
mU/mL) for 5, 10, 15, or 30 minutes, followed by removal of the reactive oxygen species
in the same manner as described in the 15 minute exposures. Uptake assays were then
performed to determine the degree of uptake inhibition at each exposure period. In the
presence of 50 mU/mL X/XO, both Na"^ and Cl'-dependent transport displayed timedependent inhibition, increasing with longer incubation times (Figure 12). At the longest
exposure time (30 minutes), both Na"^ and CI' -dependent transport systems again
displayed significant levels of inhibition, 77.8 ± 1.1% and 53.3 ± 3.1%, respectively. As
was observed with the H2O2, the free radical scavengers were able to significantly prevent
inhibition at this high level of insult (Figure 11). Figure 12 illustrates the differences in the
amount of inhibition between the Na"^ and Cl'-dependent transport systems observed at
each exposure time. A more detailed comparison of the concentration dependence with
which X/XO-induced a loss of transport activity is summarized in Table 3. Since all
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experimental conditions were equally maintained, the data once more suggest a differential
sensitivity of the Na"^ and Cl'-dependent transporters.
The possibility that the X/XO-induced inhibition resulted from a general cytotoxic
effect of the free-radical system or the agents themselves was evaluated by quantifying
the LDH content of the treated cells. Both intracellular and extracellular LDH activity was
examined. As shown in Figure 13, a 15 minute incubation with X (500 mM)/XO (50, 200,
500 mU) did not significantly decrease the intracellular LDH activity as compared to
control values. Further, a 30 minute exposure X/XO (50 mU), which induced high degrees
of uptake inhibition, produced no significant change in LDH activity from control values
(Figure 13). In each instance, the amount of extracellular LDH activity was below the
level of detectibility.

Effects of Antioxidants on Oxidative Stress Induced Glutamate Transport
Inhibition
In order to confirm that the ROS-associated mechanisms were responsible for the
inhibition produced by H2O2 and X/XO, a variety of antioxidants were tested for potential
protective activity. These compounds included: the lipohilic antioxidants a-tocopherol
(vitamain E) and methylprednisolone (MP), the hydrophilic antioxidants ascorbate
(reduced vitamin C) and reduced glutathione (GSH), and the reducing agent dithiothreitol
(DTT). a-Tocopherol

and MP were chosen for their ability to act within lipid

membranes and protect against lipid peroxidation. a-Tocopherol is the major lipid-
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soluble, chain-reaction braking antioxidant in biological systems, while MP is a clinically
used corticosteroid, that blocks lipid peroxidation at high concentrations. Both
compounds were included in the assays at a concentration (100 |iM), a level that has
previously been shown to inhibit lipid peroxidation in vitro (Agostinho et al., 1997;
Braughler et al., 1987).

Due to their hydrophobic nature, these compounds were

dissolved in 2.5% ethanol. Parallel studies demonstrated that the ethanol had no effect on
control or experimental uptake assays (data not shown). The compounds GSH, ascorbate,
and DTT were chosen because of their hydrophilic properties. Both GSH and ascorbate
are found endogenously and can protect biomolecules from ROS damage. GSH is widely
distributed within the CNS and present intracellularly at concentrations of approximately
2 mM (Ross, 1988). The CNS contains high concentrations of ascorbate, approimately 2
mM (Grunewald, 1993). At these high concentrations ascorbate will reduce free radicals
with the formation of dehydroascorbate. The compound DTT is a synthetic agent that
selectively reduces disulfides (Cleland, 1964). In each experiment the antioxidants were
added to the pretreatment simultaneously with either 1 mM H2O2 or X (500 mM)/XO (50
mU/mL). All other components of the experiments, including quantification of glutamate
uptake, were performed as described (Materials and Methods).
The potential protective effects of these compounds were first examined on the
Na^-dependent transport system. The compounds were tested individually using both
models of oxidative stress (H2O2 and X/XO) and compared to the level of inhibition
induced by 1 mM H2O2 (53.3 ± 0.9%) and X (500 mM)/XO (50 mU/mL)(60.4 ± 1.0%).
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The lipophilic antioxidants (a-tocopherol and MP), similarly failed to protect Na^dependent transport from inhibition induced by either H2O2 (Figure 14) or X/XO (Figure
15). The two hydrophilic antioxidants (ascorbate and GSH) on the other hand, produced
dramatically dissimilar results. While ascorbate was unable to prevent the inhibition of
uptake by H2O2 or X/XO, GSH substantially attenuated inhibition due to H2O2 (19.8±
1.2%) (Figure 14) and X/XO (26.6 ± 2.5%) (Figure 15). To address whether the
protection afforded by GSH was due to its ability to scavenge H2O2 or reduce sulfur
moieties, the reducing agent DTT was also tested. DTT almost completely attenuated the
inhibition produced by exposure to H2O2 (10.1 ± 2.6%) (Figure 14) or X/XO (16.1 ±
1.8%) (Figure 15).
The antioxidants and reducing agent were also tested for their capacity to preserve
Cl'-dependent transport potential during exposure to 1 mM H2O2 or X (500 wM)/XO (50
mU/mL), which produce 32.3 ± 0.6% and 34.4 ± 0.5% inhibtion, respectively (Figures 16
and 17). Initially the hydrophilic antioxidants, ascorbate and GSH, and the reducing agent
DTT were investigated. Strikingly none of these compounds prevented inhibition of
transport produced by either H2O2 (Figure 16) or X/XO (Figure 17). When the two
lipophilic antioxidants, a-tocopherol and MP were tested, it was found the corticosteroid
MP offered no protective effects, while a-tocopherol was able to significantly attenuate
inhibition due to H2O2 (22.8 + 2.4%) and X/XO (22.0 ± 0.9%). The differing efficacies of
the protective agents examined (Table 4) again demonstrate fundamental differences
between the Na"^ and Cl'-dependent transport systems.
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Table 1. High Affinity Glutamate Uptake in LRM55 Astrocytoma Cells

Transport

Rate of ^H-L-glutamate
uptake
pmol/min/mg protein

% of Total

Total

308 ±22

100

Na-dependent

212 ± 8

69 ± 6

CI -dependent

112 ± 11

36 ± 5

The uptake of ^H-L-glutamate (100 mM) in LRM55 astrocytoma cells was performed as
described in methods, with the appropriate choline and gluconate substitutions for sodium
and chloride respectively. Results are reported as mean ± SEM for at least 4 separate
experiments conducted in triplicate.
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Figure 2. Effects of H2O2 on Na^-Dependent
L-Glutamate Uptake

mm

***

5

Concentration of H2O2 (mM)

Cat/SOD

Dose-dependent inhibition of Na+-dependent glutamate uptake by hydrogen
peroxide and attenuation of the effect by free-radical scavengers. 3H-LGlutamate uptake assays were performed for 5 minutes in LRM55 cultures preexposed to control conditions (Con), 0.1, 1, 5, or 10 mM hydrogen peroxide, or
5 mM hydrogen peroxide with the free-radical scavenger mixture of SOD (90
U/ml) and Cat (3000 U/ml). Each column represents rate of glutamate uptake
and percent of control glutamate uptake. The values are presented as the mean
± SEM value obtained from 8 determinations in duplicate. The Alternate
Welch t-test reveals high statistical difference of treatments as compared to
control (*, P < 0.05, **, P < 0.01, ***, P < 0.001).

Figure 3. Effects of Free Radical Scavengers on
Inhibition of Na^-Dependent Uptake by H2O2

SOD

H2O2

Cat/SOD

Effectiveness of free-radical scavengers in protecting Na"^-dependent glutamate
transport from H202-induced inhibition. Cultured LRM55 cells were
preincubated for 15 or 30 minutes in control conditions or 1 mM H2O2 with or
without SOD (90 U/ml) and Cat (3000 U/ml) in combination or alone. The free
radical scavengers were added simultaneously with H2O2 and were present
during the entire preincubation. The columns represent percent of control ^H-Lglutamate uptake, in the indicated buffer for 5 min. The values are presented as
the mean ± SEM of at least 3 determinations in duplicate. The Alternate Welch ttest reveals high statistical difference of treatments as compared to control (*, P <
0.05, **, P < 0.01, ***, P < 0.001).
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Figure 4. Effects of H2O2 on Cl-Dependent
L-Glutamate Uptake
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Dose-dependent inhibition of Cl"-dependent glutamate uptake by hydrogen
peroxide and prevention of the effect by free-radical scavengers. ^H-L-Glutamate
uptake assays were performed for 5 or 10 minutes in LRM55 cultures preexposed to control conditions (Con), 0.1, 1, 5, or 10 mM hydrogen peroxide, or 5
mM hydrogen peroxide with the free-radical scavenger mixture of SOD (90
U/ml) and Cat (3000 U/ml). Each column represents rate of glutamate uptake and
percent of control glutamate uptake. The values are presented as the mean ±
SEM value obtained from 8 determinations in duplicate. The Alternate Welch ttest reveals high statistical difference of treatments as compared to control (*, P <
0.05, **, P < 0.01, ***, P < 0.001).

Figure 5. Effects of Free Radical Scavengers on
Inhibition of Cl"-Dependent Uptake by H2O2

MM

SOD

H2O2

Cat/SOD

Effectiveness of free-radical scavengers in protecting Cl"-dependent glutamate
transport from H202-induced inhibition. Cultured LRM55 cells were
preincubated for 15 or 30 minutes in control conditions or 1 mM H2O2 with or
without SOD (90 U/ml) and Cat (3000 U/ml) in combination or alone. The free
radical scavengers were added simultaneously with H2O2 and were present
during the entire preincubation. The columns represent percent of control 3H-Lglutamate uptake, in the indicated buffer for 5 min. The values were presented as
the mean ± SEM of at least 3 determinations in duplicate. The Alternate Welch ttest reveals high statistical difference of treatments as compared to control (*, P <
0.05, **, P < 0.01, ***, P < 0.001).
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Figure 6. H2O2 Time Course
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Preincubation (min)
Glutamate transport inhibition by hydrogen peroxide (H2O2) was time-dependent.
Inhibition of Na+ and CI- -dependent 3H-L-glutamate uptake was progressive during
exposure to 1 mM H2O2 for up to 30 minutes. For each time point, uptake after
indicated preincubation with H2O2 was compared to uptake in LRM55 cells exposed
to control conditions for the indicated time. Data points were plotted as a percentage
of inhibition ± SEM and represent three determinations in duplicate. The Alternate
Welch t-test reveals high statistical difference between treatments as compared to
controls (*, P < 0.05, *•, P < 0.01, **•, P < 0.001) and between Na+ and Ci- dependent transport (#, P < 0.05, ##, P < 0.01, ###, P < 0.001).
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Table 2. Inhibition of Na"" and Cl'-Dependent Transport Following
Exposure to

Concentration of
(mM)

Cl'-Dependent
Transport Inhibition
(% of Control)

0.1

87.8 ± 2.0

79.4 + 1.3

1.0

68.5 ± 1.7

47.7 ± 1.5

5.0

55.3 ± 0.9

37.7 ± 1.2

10.0

49.1 ± 2.4

33.1 ± 1.5

Na-Dependent
Transport Inhibition
(% of Control)

The inhibition of Na"^ and Cl'-dependent uptake of ^H-L-glutamate (100 mM) in LRJVI55
astrocytoma cells following exposure to H2O2 (0.1,1, 5, and 10 mM) for 15 minutes. The
values, reported as a percentage of contol uptake ± SEM, were obtained from 8
determinations in duplicate.
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Figure 7. Intracellular LDH Activity After
Exposure To H2O2
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LRM55 cultures were incubated for 15 or 30 minutes in control conditions or in the
presence of hydrogen peroxide (0.1, 1, 5, or 10 mM). Extracellular and intracellular
samples were tested for LDH activity. Intracellular samples were collected by
incubation with the detergent Triton X-100 (0.1%) for one hour on a rotating shaker.
The columns are presented as percent of control intracellular LDH activity and values
represent the mean ± SEM of at least 5 determinations. Each determination was
performed in duplicate and results of experiments were averaged together. In every
condition no extracellular LDH activity was detected. The Alternate Welch t-test
reveals high statistical difference of treatments as compared to controls (*, P < 0.05).
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Figure 8. Effects of X/XO on Na^-Dependent
L-Glutamate Uptake

«

mU Xanthine Oxidase

Cat/SOD

Dose-dependent inhibition of Na"'"-dependent glutamate uptake by the xanthine/ xanthine
oxidase free-radical generating system and prevention of the effect by free-radical
scavengers. ^H-L-Glutamate uptake assays were performed for 5 minutes in LRM55
cultures pre-exposed to control conditions (Con), 500 wM xanthine alone (X), 50 mU/ml
xanthine oxidase alone (XO), xanthine/xanthine oxidase (500 mM/5, 50, 200, or 500
mU/ml), or xanthine/xanthine oxidase (500 mM/50 mU/ml) with the free-radical
scavenger mixture of SOD (90 U/ml) and Cat (3000 U/ml). Each column represents rate
of glutamate uptake and percent of control glutamate uptake. The values are presented as
the mean ± SEM value obtained from 8 determinations in duplicate. The Alternate
Welch t-test reveals high statistical difference of treatments as compared to control (*, P
< 0.05, **, P < 0.01, ***, P < 0.001).
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Figure 9. Effects of Free Radical Scavengers on
Inhibition of Na^-Dependent Uptake by X/XO
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Effectiveness of free-radical scavengers in protecting Na+-dependent glutamate transport
from xanthine/xanthine oxidase (X/XO)-induced inhibition. Cultured LRM55 cells were
preincubated for 15 or 30 minutes in control conditions or X (500 mM)/XO (50 mU/ml)
with or without SOD (90 U/ml) and Cat (3000 U/ml) in combination or alone. The free
radical scavengers were added simultaneously with X /XO and were present during the
entire preincubation. The columns represent percent of control ^H-L-glutamate uptake, in
the indicated buffer for 5 min. The values are presented as the mean ± SEM of at least 3
determinations in duplicate. The Alternate Welch t-test reveals high statistical difference
of treatments as compared to exposure to control (*, P < 0.05, **, P < 0.01, ***, P <
0.001).
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Figure 10. Effects of X/XO on Cl"-Dependent
L-Glutamate Uptake

mil of Xanthine Oxidase

Cat/SOO

Dose-dependent inhibition of Cl'-dependent glutamate uptake by the xanthine/
xanthine oxidase free-radical generating system and prevention of the effect by freeradical scavengers. ^H-L-Glutamate uptake assays were performed for 5 or 10
minutes in LRM55 cultures pre-exposed to control conditions (Con), 500 wM
xanthine (X), 50 mU/ml xanthine oxidase alone (XO), xanthine/xanthine oxidase (500
WM/5, 50, 200, or 500 mU/ml), or xanthine/xanthine oxidase (500 mM/50 mU/ml)
with the free-radical scavenger mixture SOD (90 U/ml) and Cat (3000 U/ml). Each
column represents rate of glutamate uptake and percent of control glutamate uptake.
The values are presented as the mean ± SEM value obtained from 8 determinations in
duplicate. The Alternate Welch t-test reveals high statistical difference of treatments
as compared to control (*, P < 0.05, **, P < 0.01, ***, P < 0.001).
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Figure 11. Effects of Free Radical Scavengers
on Inhibition of Cl"-Dependent Uptake by X/XO
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Effectiveness of free-radical scavengers in protecting Cl -dependent glutamate
transport from xanthine/xanthine oxidase (X/XO)-induced inhibition. Cultured
LRM55 cells were preincubated for 15 or 30 minutes in control conditions or X (500
mM)/XO (50 mU/ml) with or without SOD (90 U/ml) and Cat (3000 U/ml) in
combination or alone. The free radical scavengers were added simultaneously with
X /XO and were present during the entire preincubation. The columns represent
percent of control ^H-L-glutamate uptake, in the indicated buffer for 5 min. The
values are presented as the mean ± SEM of at least 3 determinations in duplicate.
The Alternate Welch t-test reveals high statistical difference of treatments as
compared to exposure to control (*, P < 0.05, **, P < 0.01, ***, P < 0.001).

Figure 12. X/ XO Time Course
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Glutamate transport inhibition by xanthine/xanthine oxidase (X/XO) was timedependent. Inhibition of Na+ and CI- -dependent ^H-L-glutamate uptake was
progressive during exposure to X (500 mM)/XO (50 mU/ml) for up to 30 minutes.
For each time point, uptake after indicated preincubation with X/XO was compared
to uptake in LRM55 cells exposed to control conditions for the indicated time. Data
points were plotted as a percentage of inhibition ± SEM and represent three
determinations in duplicate. The Alternate Welch t-test reveals high statistical
difference of treatments as compared to controls (*, P < 0.05; **, P < 0.01; ***, P <
0.001) and between Na+ and CI- -dependent transport (#, P < 0.05; ##, P < 0.01;
###, P < 0.001).
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Table 3. Inhibition of Na^ And Q'-Dependent Transport Following
Exposure to X/XO

Concentration of
XO
(mU)

Cl'-Dependent
Transport Inhibition
(% of Control)

Na-Dependent
Transport Inhibition
(% of Control)

5

94.1 ± 3.4

84.4 ± 1.8

50

67.5 ± 3.9

38.1 ± 3.7

200

47.4 ± 2.4

19.0 ± 3.8

500

42.2 ± 2.5

15.5 ± 3.9

The inhibition of Na^ and Cl'-dependent uptake of ^H-L-glutamate (100 mM) in LRM55
astrocytoma cells by exposure to (500 wM) X/XO(5, 50, 200, 500 mU) for 15 minutes.
The values are reported as percentage of contol uptake ± SEM and obtained from 8
determinations in duplicate.

Figure 13. Intracellular LDH Activity After
Exposure To X/XO
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LRM55 cultures were incubated for 15 or 30 minutes in control conditions or in the
presence of xanthine/xanthine oxidase (500 wM/50, 200, or 500 mU/ml).
Extracellular and intracellular samples were tested for LDH activity. Intracellular
samples were collected by incubation with the detergent Triton X-100 (0.1%) for
one hour on a rotating shaker. The columns are presented as percent of control
intracellular LDH activity and values represent the mean ± SEM of at least 5
determinations. Each determination was performed in duplicate and results of
experiments were averaged together. In every condition no extracellular LDH
activity was detected. The Alternate Welch t-test reveals high statistical difference
of treatments as compared to controls (*, P < 0.05).
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Figure 14. Na"*"-Dependent Glutamate Uptake:
Effectiveness of Various Antioxidants
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Effectiveness of antioxidants in protecting Na+ -dependent glutamate transport
from H202-induced inhibition. Cultured LRM55 cells were preincubated for 15
minutes in control conditions or 1 mM H2O2 in the presence or absence of the
antioxidants. The antioxidants a-tocopherol (100 mM), methylprednisolone (100
mM), ascorbate (2 mM), reduced glutathione (2 mM), or dithiothreitol (2 mM) were
added simultaneously with X/XO and present during the entire preincubation. The
columns represent percent of control ^H-L-glutamate uptake, in the indicated
buffer for 5 min. The values are presented as the mean ± SEM of 6 determinations
in duplicate. The Alternate Welch t-test reveals high statistical difference of
treatments as compared to 1 mM H2O2 (*, P < 0.05; **, P < 0.01; ***, P < 0.001).

Figure 15. Na+-Dependent Glutamate Uptake:
Effectiveness of Various Antioxidants

Effectiveness of antioxidants in protecting Na+ -dependent glutamate transport
from X/XO-induced inhibition. Cultured LRM55 cells were preincubated for 15
minutes in control conditions or X (500 mM)/XO (50 mU/ml) in the presence or
absence of the antioxidants. The antioxidants a-tocepherol (100 mM),
methylprednisolone (100 mM), ascorbate (2 mM), reduced glutathione (2 mM), or
dithiothreitol (2 mM) were added simultaneously with X/XO and present during
the entire preincubation. The columns represent percent of control ^H-L-glutamate
uptake, in the indicated buffer for 5 min. The values are presented as the mean ±
SEM of 6 determinations in duplicate. The Alternate Welch t-test reveals high
statistical difference of treatments as compared to X (500 mM)/XO (50 mU/ml) (*,
P < 0.05, **, P < 0.01, ***, P < 0.001).
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Figure 16. Cl'-Dependent Glutamate Uptake:
Effectiveness of Various Antioxidants
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Effectiveness of antioxidants in protecting CI" -dependent glutamate transport
from H20)-induced inhibition. Cultured LRJVI55 cells were preincubated for 15
minutes in control conditions or 1 mM H2O2 in the presence or absence of the
antioxidants. The antioxidants a-tocopherol (100 mM), methylprednisolone (100
mM), ascorbate (2 mM), reduced glutathione (2 mM), or dithiothreitol (2 mM)
were added simultaneously with X/XO and present during the entire
preincubation. The columns represent percent of control ^H-L-glutamate uptake,
in the indicated buffer for 5 min. The values are presented as the mean ± SEM of
6 determinations in duplicate. The Alternate Welch t-test reveals high statistical
difference of treatments as compared to 1 mM H2O2 (*, P < 0.05).

Figure 17. Cl"-Dependent Glutamate Uptake:
Effectiveness of Various Antioxidants
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Effectiveness of antioxidants in protecting CI" -dependent glutamate transport
from X/XO-induced inhibition. Cultured LRM55 cells were preincubated for 15
minutes in control conditions or X (500 mM)/XO (50 mU/ml) in the presence or
absence of the antioxidants. The antioxidants a-tocopherol (100 mM),
methylprednisolone (100 wM), ascorbate (2 mM), reduced glutathione (2 mM), or
dithiothreitol (2 mM) were added simultaneously with X/XO and present during
the entire preincubation. The columns represent percent of control ^H-L-glutamate
uptake, in the indicated buffer for 5 min. The values are presented as the mean ±
SEM of 6 determinations in duplicate. The Alternate Welch t-test reveals high
statistical difference of treatments as compared to X (500 wM)/XO (50 mU/ml) (*,
P < 0.05, **, P < 0.01, ***, P < 0.001).
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Table 4. Effectiveness of Antioxidants in Protecting Na^ And Cl Dependent Transport from Oxidative Stress

Antioxidant

Na+'Dependent Uptake CI-Dependent Uptake
(% of Control)
(% of Control)
H2O2

X/XO

Hz O2

X/XO

Experimental

46.7 ± 0.9

39.6 ± 1.0

67.7 ±0.6

65.6 ± 0.5

a -Tocopheroi

48.0 ± 1.3

41.2 ± 1.4

77.2 ± 2.4

78.0 ± 0.9

MP

46.5 ± 0.9

39.1 ±2.2

65.5 ± 2.4

68.8 ± 4.3

Ascorbate

46.9 ± 1.3

44.0 ± 1.6

65.7 ± 2.3

65.1 ± 1.0

GSH

80.2 ± 1.2

73.4 ± 2.5

68.0 ± 1.3

65.4 ± 1.0

DTT

89.9 ± 2.6

83.9 ± 1.8

66.1 ± 1.5

64.5 ± 0.5

The values demonstrate the efficacy of antioxidants to attenuate the inhibition of Na"^ and
Cl'-dependent transport by H2O2 (1 mM) and (500 mM) X/XO (50 mU). Values are
presented as percentage of control ± SEM based upon 6 determinations in duplicate.
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DISCUSSION
As described in the introduction excitotoxicity and oxidative stress have emerged
as prominent pathological mechanisms involved in many CNS neurodegenerative diseases.
Originally characterized as separate pathological schemes, there is now evidence that
oxidative stress and excitotoxicity may be at least partially interdependent and possibly
act in concert in producing neurodegeration. Recent studies report that 1) oxidative stress
can increase the release of EAA (Rego et al., 1996), 2) glutamate toxicity can be
attenuated with free radical scavengers (Miyamoto et al., 1989), and 3) excessive release
of EAA under ischemic conditions is blocked by free radical scavengers and reproduced
by free radical-generating systems (Pellegrini-Gampietro et al., 1990). In addition, studies
have demonstrated that oxidative stress can inhibit high-affinity glutamate transport in
astrocytes (Volterra et al., 1994, Piani et al, 1993). Given that the dysfunction of highaffinity glutamate transport constitutes one of the major components of excitotoxicity
(Bridges et al., 1994; Coyle and Puttfarcken, 1993; Robinson et al., 1993; Rothstein et al.,
1996), the effect of oxidative stress on transport presents a significant mechanism by
which oxygen free

radicals and excitotoxicity may act in concert and perhaps

synergistically in the progression of CNS pathology.

Significantly,

however,

investigations to this point have only examined Na^-dependent uptake, failing to address
what affects ROS may have on Cl'-dependent uptake. In the present study, H2O2 and
X/XO were employed to investigate the consequences of oxidative stress on both the Na"^
and Cl'-dependent glutamate transporter systems. In addition, the ability of various
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antioxidants to prevent uptake inhibition induced by oxidative stress was explored. The
results of this study demonstrated that oxidative stress reduces in a time and dosedependent manner the activity of both the Na"^ and Cl'-dependent glutamate transporters.
Hydrogen peroxide is perpetually generated during routine cellular functioning of
the CNS by superoxide dismutase and other oxidative enzymes (Halliwell, 1992). Under
pathological conditions H2O2 levels have been reported to rise to at least 100 |iM
(Hyslop et al, 1995). Once generated, the high cellular permeability and relatively low
reactivity of H2O2 allows this free radical to disperse to oxidatively-sensitive sites (Wang
and Floor, 1998). At these sites H2O2 can act directly as a weak oxidizing agent or by
reacting with free iron to form a powerful oxidant, the hydroxyl radical. Consequently
H2O2 is an extremely important endogenous ROS and an appropriate agent to use
experimentally. In LRJVI55 cultures H2O2 was able to significantly inhibit both Na"^ and
Cl'-dependent glutamate uptake at all concentrations examined. Furthermore, as long as
the cultures were exposed to H2O2, inhibition of both transport systems increased with
time. The lack of an observed release of cytosolic LDH from LRM55 cells, demonstrated
that the reduction in glutamate uptake was not due to cell death. Consistent with ROSmediated damage, the H2O2 scavenger catalase was able to prevent the inhibition of Na"^
and Cl'-dependent glutamate uptake by H2O2 exposure, while SOD was ineffective.
Therefore, indicating that the H2O2 was metabolized before it generated other ROS
species.
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Although both Na"^ and Cl'-dependent transport was specifically inhibited by
exposure to H2O2, the two systems did display a differing sensitivity to the oxidative
stress. As an index of this selective vulnerability, a 1 mM concentration of H2O2 resulted
in a 52% decrease in Na^-dependent uptake, while Cl'-dependent uptake was decreased
by only 31%. This divergence was observed at essentially all oxidative challenges. These
results imply a fundamental difference between the two transport systems. This
difference could be a result of one transporter being more vulnerable to oxidative injury,
possibly as a consequence of its content of oxidation-sensitive amino acids. Several
potential oxidatively sensitive amino acids have been identified on a cloned Na"^dependent transporter (Pines et al., 1992). As the Cl'-dependent transporter has not yet
been cloned, differences in primary structure and oxidation-sensitive amino acids await
future work. Another factor to consider is that there may be differences in vulnerability
due to a decrease in the cellular repair mechanisms responsible for maintaining each
transporter's function. Thus, it is possible that oxidative stress may differentially effect
endogenous repair mechanisms, leaving one transporter more vukierable to oxidation than
the other.
The X/XO free-radical generating system is another classic inducer of oxidative
stress. The enzyme XO converts X to uric acid with the concurrent generation of one
H2O2 molecule and one superoxide ion. As previously described, superoxide is a ROS that
has been implicated in the development of CNS injury following trauma or ischemia.
Analogous to H2O2, the superoxide ion is formed in vivo in a variety of ways. There is
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increasing evidence, though, that the reaction of XO with hypoxanthine (an endogenous
substrate for the enzyme) is an important source of superoxide (McCord, 1985). XO in
vivo is derived from xanthine dehydrogenase (XDH). Conversion of XDH to XO can
occur either reversibly by oxidation of sulfhydryl groups or irreversibly by limited
proteolysis of the enzyme (McCord, 1985). The latter, which is catalyzed by calciumdependent calpains (McCord, 1985), could potentially be activated by the increase in
intracellular calcium prevalent during excitotoxicity (Choi, 1992). Given that X/XO is a
relevent source of free radicals, it was a suitable choice for a second oxidative challenge.
Analogous to the effects of H2O2, LRM55 cells exposed to X/XO exhibited a
decrease in the Na"^ and Cl'-dependent transport activity that was time and concentrationdependent. Similarly, X/XO-induced inhibition of glutamate uptake was not associated
with any decrease in cytosolic LDH activity. Therefore, the decrease in transport induced
by X/XO cannot be attributed to a loss of cell viability. Control experiments did however,
demonstrate an ability of XO alone to inhibit glutamate uptake. This same effect was
observed in a previous study and postulated to be a result of proteolytic contamination of
the enzyme as purchased from Sigma (Volterra et al., 1994). Due to this contamination
the total level of inhibition of transport observed cannot be attributed solely to the effects
of ROS. Importantly the similar effects of both H2O2 and X/XO support the conclusion
that the majority of inhibition with X/XO exposure was due to oxidative mechanisms.
Investigations with the scavenger enzymes SOD (90 U/mL) and Cat (3000 U/mL)
also produced results consistent with ROS-mediated damage generated by the X/XO
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system. The free-radical

scavengers in combination completely prevented uptake

inhibition of the two transport systems while SOD or Cat alone was only partially
effective. The limited efficacy exhibited by the singular enzymes is consistent with
multiple ROS being generated by the X/XO system and the enzymatic specificity of the
two ROS scavengers. Evaluation of X/XO-mediated inhibition of the two transport
processes, again illustrated the greater susceptibility of the Na^-dependent transporter to
oxidative stress.
Collectively, the results of the described experiments with H2O2 and X/XO
illustrates the susceptibility of Na"'"-dependent transport to oxidative stress. These results
corroborate the investigations by Volterra et al. (1994), Piani et al. (1993), and Sorg et al.
(1997) which previously demonstrated that H2O2 or X/XO is able to inhibit glutamate
uptake in astrocytes. Further, the sensitivity reported by Volterra et al. (1994) was very
similar to what was found in the present study. For example, ten minutes incubation with
500uM X/50mU XO resulted in approximately a 40% decrease of uptake in both
investigations. This similar sensitivity suggests a shared vulnerability of both the spinal
and cortical systems.
This study is the first to demonstrate the inhibition of Cl'-dependent glutamate
transport by acute exposure to oxidative stress. Most significantly, the experiments with
H2O2 and X/XO indicated a differential sensitivity of Na"^ and Cl'-dependent transporters
to oxidative stress. Studies with other transport systems, specifically GABA, have
demonstrated a similar susceptibility to damage by oxidative stress (Braughler, 1985).
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This susceptibility cannot, however, be generalized to all transporters as comparable
levels of oxidative stress actually increase the uptake of dopamine (Rafalowska et al.,
1989). The relative insensitivity of Cl'-dependent transport in the present study suggests
that during pathological conditions Cl'-dependent transport may assume a more
prominent role in controlling the levels of extracellular glutamate.
To further examine the conclusion that oxidative stress was responsible for the
loss of Na"^ and Cl'-dependent transport, the potential protection by various antioxidants
was evaluated. In the first set of studies examining the Na^-dependent transport system
the two lipophilic antioxidants, at concentrations high enough to block lipid peroxidation
in vitro (Braughler et al., 1987; Agostinho et al., 1997), failed to prevent the decrease in
uptake. In contrast, the disulfide-reducing agents GSH and DTT largely prevented the
loss of activity. These results were in agreement with previous work by Volterra et al.
(1994) and Agostinho et al. (1997) which showed a similar level of protection by GSH
and DTT. The observed effect of GSH in preventing the inhibition of Na^-dependent
transport was probably due to its capacity to reduce thiol groups, since a similar effect
was obtained with the synthetic selective disulfide reducing agent DTT. While
interpreting these results it is important to consider the possible effects of GSH and DTT
could have on the enzyme XO itself. The enzyme contains sulhydryl groups that,
depending upon their redox state, can alter function. Therefore it is significant that DTT
displayed an analogous ability to prevent H2O2 induced transport inhibition. Taken
together, the data suggest that oxidation of protein thiol groups, rather than lipid
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peroxidation, is likely to represent the mechanism leading to inhibition of Na^-dependent
transport by oxidative stress. Notably, a cloned gUal Na^-dependent transporter carries
both a single cysteine in its major external loop and two close cysteins in a membranespanning domain (Pines et al., 1992).
When the same compounds were employed to examine the vulnerability of the CI"
-dependent transport, a dramatic difference was observed.

Unlike Na^-dependent

transport, the hydrophilic antioxidants were unable to attenuate transport inhibition. The
lipophilic antioxidant a-tocopherol however, was able to significantly decrease the
inhibition of Cl'-dependent uptake induced by oxidative stress. The results suggest that in
contrast to the Na^-dependent transporter, the Cl'-dependent transporter probably does
not contain sulfhydryl groups readily sensitive to oxidation. Based upon the mechanism
of action of a-tocopherol, it is likely that inhibition of Cl'-dependent transport is related
to the oxidation of lipid-associated macromolecules. These differences in protection by
the examined anti-oxidants supports the conclusion that distinct oxidative mechanisms are
responsible for inhibiting the two transport systems.
The inhibition of the glutamate transport systems by oxidative stress, as
demonstrated in this study should be considered within the schemes of possible
mechanisms of neuropathology. Previous investigations have reported that inhibition of
glutamate uptake can model both slow and acute neurodegeneration (Okazaki et al., 1996;
Rothstein et al., 1993). In vitro, intracerebroventricular injection of antisense
oligonucleotides to GLT-1 (the rodent homologue of EAAT-2) produces excitotoxic-like
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cell damage in the brain (Rothstein et al., 1996), while glutamate uptake blockers cause
motomeuron death in organotypic spinal cord cultures (Rothstein et al., 1993). There is
now evidence that several CNS pathologies, including ALS and Alzheimer's disease are
clearly associated with a decrease in glutamate transport function. Post-mortem studies
with synaptosomes prepared from patients with ALS exhibited a marked decrease in
glutamate uptake (Rothstein et al., 1992). This effect was specific for glutamate transport
as the uptake of GABA and phenylalanine were unaffected. The deficit was subsequently
attributed to the selective loss of the glial transporter, GLT-1 (Rothstein, 1995).
Interestingly, genetic linkage between a familial variant of ALS (which represents 10-15%
of the ALS cases) and defects in the gene encoding for a cytosolic form of SOD enzyme
have been reported (Rosen, 1993). Recently, deficient glutamate transport has been
associated with neurodegeneration in Alzheimer's disease (AD). The amyloid beta
peptide (A-beta), a hallmark of AD was shown to significantly inhibit glutamate uptake
in astrocyte cultures (Harris et al., 1996). A proposed mechanism of the inhibition was
the formation of free radicals by A-beta, providing another possible link between
oxidative stress and excitotoxicity.
An alternate mechanism of excitotoxicity is the inhibition of cystine uptake
through the system Xc" antiporter by extracellular glutamate (Murphy et al., 1989; Pereira
and Oliveira, 1997). Cystine is believed to be the rate-limiting precursor for GSH
synthesis (Bannai and Tateishi, 1986). Thus inhibition of cystine uptake leads to
depletion of cellular GSH levels and a delayed cellular toxicity (Coyle and Puttfarcken,
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1993; Kato et al., 1993). The cell death results from oxidative stress after depletion of
GSH. As previously mentioned, GSH is an important endogenous antioxidant responsible
for maintenance of protein thiol status within cells, a role that is vital during episodes of
oxidative stress. Most significantly, evidence has been presented that Cl'-dependent
glutamate transport as present in this cell line may actually represent the system X^'
antiporter (Murphy et al., 1989; Patel et al., 1998). If correct, this provides another
mechanism by which dysfunction of the EAA system and oxidative stress may cooperate
in the genesis of neurotoxic injury.
In conclusion, the present study has demonstrated that both the Na^ and Cl'dependent glutamate transport systems are susceptible to oxidative stress. The evidence
indicates that the two transport systems are differentially sensitive to ROS and that this
may be attributable to distinct mechanisms of inhibition induced by the oxidative stress.
The findings

suggest the Na^-dependent transport system, acknowledged as the

prominent regulator of extracellular glutamate may be first to be damaged. Further, the
apparent decreased susceptability of the Cl'-dependent system to ROS-mediated damage
indicates that the system may play a more significant role in preventing glutamate toxicity
during pathological states. Finally, in view of the present data, potential therapeutics will
need to intermpt the distinct mechanisms of ROS-mediated glutamate transport inhibition
in order to maintain transport functioning and prevent glutamate-mediated damage.
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